Israel's Pluristem develops breakthrough radiation poisoning therapy
Placenta-based cell therapy developer Pluristem Therapeutics, together with the US Department of Defense, conduct a successful series of studies with PLX-R18 ...
Placenta-based cell therapy developer Pluristem Therapeutics, together with the US Department of Defense, conduct a successful series of studies with PLX-R18 ...
So far the vaccine has been proven effective in mice in preventing the development of melanoma and in treating primary ...
Majority of measles cases have been reported in NY's Orthodox Jewish communities. Bronx Democrat Jeffrey Dinowitz: "I'm not aware of ...
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]